tiprankstipranks
Trending News
More News >
Clal Insurance Enterprises Holdings Limited (IL:CLIS)
:CLIS
Israel Market

Clal Insurance (CLIS) AI Stock Analysis

Compare
1 Followers

Top Page

IL:CLIS

Clal Insurance

(CLIS)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
24,570.00
▲(9.25% Upside)
Clal Insurance's overall stock score is driven by strong technical indicators and a favorable valuation, despite some financial performance concerns. The stock's bullish momentum and undervaluation are significant positives, but investors should be cautious of the potential risks associated with revenue decline and increased leverage.
Positive Factors
Profitability
High gross profit margins and improved net profit margins indicate efficient cost management and enhanced operational efficiency, supporting long-term profitability.
Operational Efficiency
Improved EBIT and EBITDA margins reflect better operational efficiency, which can lead to sustained profitability and competitive advantage over time.
Return on Equity
Improved return on equity indicates effective management in utilizing shareholder funds to generate profits, enhancing investor confidence and long-term growth potential.
Negative Factors
Revenue Decline
A significant revenue decline poses risks to growth and market position, potentially impacting long-term financial stability and strategic initiatives.
Increased Leverage
Increased leverage can strain financial flexibility and elevate risk, potentially affecting the company's ability to invest in growth opportunities.
Cash Flow Challenges
Declining free cash flow growth indicates potential issues in cash generation, which can limit the company's ability to fund operations and investments sustainably.

Clal Insurance (CLIS) vs. iShares MSCI Israel ETF (EIS)

Clal Insurance Business Overview & Revenue Model

Company DescriptionClal Insurance Enterprises Holdings Ltd. provides insurance services in Israel. It operates through three segments: Long-Term Savings, Non-Life insurance, and Health Insurance. The Long-Term Savings segment offers life insurance products and accompanying coverages; long-term savings for various insurance policies, and pension and provident funds, including study funds; and insurance coverage for various risks, such as death, disability, loss of working capacity, and health insurance policies. The Non-life Insurance segment offers third party, employers', professional, and product liability insurance products; credit and foreign trade risks; and property, motor, personal accident, and other insurance products, as well as guarantees. The Health Insurance segment provides long-term care, medical expenses, surgeries, transplants, personal accidents, international travel, dental, foreign workers, and other insurance products. Clal Insurance Enterprises Holdings Ltd. was incorporated in 1987 and is based in Tel Aviv-Yafo, Israel.
How the Company Makes MoneyClal Insurance generates revenue primarily through the collection of premiums from its various insurance products, including life, health, and property insurance. The company earns money by underwriting insurance policies, where it assesses risk and sets premium rates accordingly. Additionally, Clal Insurance invests the premiums it collects into various financial markets, generating investment income. Key revenue streams include individual policyholder premiums, group insurance contracts, and investment returns from the managed assets within its portfolio. The company may also engage in strategic partnerships with financial institutions and other entities to offer bundled services, enhancing its market reach and revenue potential.

Clal Insurance Financial Statement Overview

Summary
Clal Insurance demonstrates strong profitability with high gross profit margins and improved net profit margins. However, the significant revenue decline and increased leverage in the TTM period are concerning. Cash flow metrics indicate challenges in cash generation, although the company maintains a healthy free cash flow to net income ratio. Overall, while profitability is strong, the company faces risks related to revenue growth and leverage.
Income Statement
65
Positive
Clal Insurance shows strong gross profit margins consistently above 97%, indicating efficient cost management. However, the company experienced a significant revenue decline of 15.34% in the TTM period, which is concerning. The net profit margin improved to 5.04% in the TTM, reflecting better profitability compared to previous years. EBIT and EBITDA margins have also improved, suggesting enhanced operational efficiency.
Balance Sheet
60
Neutral
The debt-to-equity ratio increased to 1.66 in the TTM, indicating higher leverage, which could pose financial risks. However, the return on equity improved to 15.13%, showing effective use of equity to generate profits. The equity ratio remains stable, reflecting a balanced capital structure.
Cash Flow
55
Neutral
The free cash flow growth rate declined by 26.46% in the TTM, highlighting cash flow challenges. The operating cash flow to net income ratio is zero, indicating potential issues in converting income to cash. However, the free cash flow to net income ratio remains healthy at 76.43%, suggesting adequate cash generation relative to net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue23.69B26.83B21.45B7.31B25.06B14.64B
Gross Profit23.93B25.93B20.43B6.11B24.00B13.60B
EBITDA4.12B2.33B1.46B729.00M2.14B1.07B
Net Income1.87B718.00M220.00M121.00M1.08B438.68M
Balance Sheet
Total Assets183.67B170.10B163.62B144.62B145.51B124.48B
Cash, Cash Equivalents and Short-Term Investments6.34B20.15B8.64B13.90B26.53B17.72B
Total Debt15.75B775.00M777.00M5.13B4.86B4.64B
Total Liabilities173.51B160.57B154.97B136.56B137.73B118.13B
Stockholders Equity10.08B9.45B8.58B8.00B7.72B6.30B
Cash Flow
Free Cash Flow992.00M1.32B-4.64B-2.80B6.87B-1.47B
Operating Cash Flow1.29B1.38B-4.31B-2.59B7.09B-1.25B
Investing Cash Flow-2.34B-1.08B-2.24B-365.96M-162.00M-379.62M
Financing Cash Flow553.00M-79.00M1.44B785.33M16.00M-194.31M

Clal Insurance Technical Analysis

Technical Analysis Sentiment
Positive
Last Price22490.00
Price Trends
50DMA
21362.80
Positive
100DMA
19607.00
Positive
200DMA
16506.02
Positive
Market Momentum
MACD
608.90
Negative
RSI
69.78
Neutral
STOCH
94.71
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:CLIS, the sentiment is Positive. The current price of 22490 is above the 20-day moving average (MA) of 22012.50, above the 50-day MA of 21362.80, and above the 200-day MA of 16506.02, indicating a bullish trend. The MACD of 608.90 indicates Negative momentum. The RSI at 69.78 is Neutral, neither overbought nor oversold. The STOCH value of 94.71 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:CLIS.

Clal Insurance Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
₪41.55B13.614.19%12.22%71.58%
76
Outperform
₪32.43B13.5223.23%2.21%5.84%138.80%
71
Outperform
₪27.45B13.372.61%23.28%124.99%
70
Outperform
₪18.73B13.440.30%6.00%36.33%
69
Neutral
₪19.16B10.171.67%-27.87%229.49%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
60
Neutral
₪3.66B10.635.98%19.48%53.61%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:CLIS
Clal Insurance
24,090.00
14,304.80
146.19%
IL:HARL
Harel
15,850.00
9,851.93
164.25%
IL:MGDL
Migdal Insur.
1,800.00
1,025.10
132.29%
IL:PHOE
Phoenix
16,390.00
10,327.50
170.35%
IL:MMHD
Menora Miv Hld
44,400.00
27,845.94
168.21%
IL:IDIN
Idi Insur
24,690.00
10,041.71
68.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025